Bydureon BCise), liraglutide (Victoza, Saxenda), and lixisenatide (Adlyxin). This drug class, involving injectable and oral medications used for weight-loss and diabetes, delays gastric emptying ...

New phase 3 data has shown Sanofi’s diabetes combination therapy, LixiLan (insulin glargine+lixisenatide ... liraglutide), after both received the backing of advisers to the US Food and Drug ...

2012;46(5):710-717. PubMed was queried (to December 5, 2011) using the search terms exenatide, liraglutide, albiglutide, and lixisenatide. The search was limited to studies published in English ...

Sanofi has finally had is type 2 diabetes drug, lixisenatide, approved in the US, creating further competition against Novo Nordisk’s market leading Victoza. The French pharma withdrew its US ...

Objective: To review drug interaction studies of glucagon ... using the terms exenatide, liraglutide, albiglutide, and lixisenatide. The search was limited to studies published in English and ...